3'-o-(4-benzoyl)benzoyladenosine 5'-triphosphate has been researched along with niacinamide in 2 studies
| Studies (3'-o-(4-benzoyl)benzoyladenosine 5'-triphosphate) | Trials (3'-o-(4-benzoyl)benzoyladenosine 5'-triphosphate) | Recent Studies (post-2010) (3'-o-(4-benzoyl)benzoyladenosine 5'-triphosphate) | Studies (niacinamide) | Trials (niacinamide) | Recent Studies (post-2010) (niacinamide) |
|---|---|---|---|---|---|
| 420 | 1 | 143 | 13,381 | 1,097 | 5,797 |
| Protein | Taxonomy | 3'-o-(4-benzoyl)benzoyladenosine 5'-triphosphate (IC50) | niacinamide (IC50) |
|---|---|---|---|
| Chain A, NAD-dependent deacetylase | Thermotoga maritima | 1000 | |
| Fatty-acid amide hydrolase 1 | Rattus norvegicus (Norway rat) | 3.3 | |
| NAD-dependent protein deacetylase sirtuin-2 | Homo sapiens (human) | 2.9 | |
| NAD-dependent protein deacetylase sirtuin-3, mitochondrial | Homo sapiens (human) | 8.1 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aluisio, L; Ao, H; Bhattacharya, A; Bonaventure, P; Fraser, I; Letavic, MA; Lord, B; Lovenberg, TW; Neff, RA; Nepomuceno, D; Shoblock, JR; Wang, Q; Welty, N; Wickenden, AD | 1 |
| Alves, M; Arribas-Blázquez, M; Artalejo, AR; Bhattacharya, A; Conroy, RM; Delanty, N; Diaz-Hernandez, M; Engel, T; Farrell, MA; Henshall, DC; Jimenez-Pacheco, A; Letavic, M; Miras-Portugal, MT; O'Brien, DF; Olivos-Oré, LA; Sanz-Rodriguez, A | 1 |
2 other study(ies) available for 3'-o-(4-benzoyl)benzoyladenosine 5'-triphosphate and niacinamide
| Article | Year |
|---|---|
Pharmacological characterization of a novel centrally permeable P2X7 receptor antagonist: JNJ-47965567.
Topics: Adenosine Triphosphate; Analgesics; Animals; Antidepressive Agents; Antimanic Agents; Behavior, Animal; Binding, Competitive; Bipolar Disorder; Blood-Brain Barrier; Brain; Calcium Signaling; Capillary Permeability; Cell Line; Depression; Disease Models, Animal; Dogs; Dose-Response Relationship, Drug; Humans; Interleukin-1beta; Macaca; Male; Mice; Mice, Inbred C57BL; Neuralgia; Niacinamide; Piperazines; Protein Binding; Purinergic P2X Receptor Antagonists; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P2X7; Time Factors; Transfection | 2013 |
Transient P2X7 Receptor Antagonism Produces Lasting Reductions in Spontaneous Seizures and Gliosis in Experimental Temporal Lobe Epilepsy.
Topics: Adenosine Triphosphate; Adolescent; Adult; Animals; Brain; Calcium-Binding Proteins; Disease Models, Animal; Epilepsy, Temporal Lobe; Gene Expression Regulation; Gliosis; Green Fluorescent Proteins; Humans; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microfilament Proteins; Middle Aged; Nerve Tissue Proteins; Niacinamide; Piperazines; Platelet Aggregation Inhibitors; Purinergic P2X Receptor Antagonists; Receptors, Purinergic P2X7; Seizures; Up-Regulation; Young Adult | 2016 |